Vainio H - Search Results

1

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. Sillanpää P, et al. Among authors: vainio h. Pharmacogenet Genomics. 2005 Oct;15(10):749-52. doi: 10.1097/01.fpc.0000172240.34923.46. Pharmacogenet Genomics. 2005. PMID: 16141802

2

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: vainio h. Pharmacogenetics. 2002 Jan;12(1):67-72. doi: 10.1097/00008571-200201000-00009. Pharmacogenetics. 2002. PMID: 11773866

3

N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk.

Wikman H, Piirilä P, Rosenberg C, Luukkonen R, Kääriä K, Nordman H, Norppa H, Vainio H, Hirvonen A. Wikman H, et al. Among authors: vainio h. Pharmacogenetics. 2002 Apr;12(3):227-33. doi: 10.1097/00008571-200204000-00007. Pharmacogenetics. 2002. PMID: 11927838

4

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: vainio h. Pharmacogenetics. 2004 Apr;14(4):239-45. doi: 10.1097/00008571-200404000-00003. Pharmacogenetics. 2004. PMID: 15083068

5

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: vainio h. Int J Cancer. 2005 Apr 20;114(4):579-84. doi: 10.1002/ijc.20677. Int J Cancer. 2005. PMID: 15609332

6

CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population.

Sillanpää P, Heikinheimo L, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Metsola K, Hirvonen A. Sillanpää P, et al. Among authors: vainio h. Breast Cancer Res Treat. 2007 Sep;104(3):287-97. doi: 10.1007/s10549-006-9414-6. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063266

7

Genetic polymorphisms of xenobiotic-metabolizing enzymes influence the risk of pulmonary emphysema.

Kukkonen MK, Hämäläinen S, Kaleva S, Vehmas T, Huuskonen MS, Oksa P, Vainio H, Piirilä P, Hirvonen A. Kukkonen MK, et al. Among authors: vainio h. Pharmacogenet Genomics. 2011 Dec;21(12):876-83. doi: 10.1097/FPC.0b013e32834d597f. Pharmacogenet Genomics. 2011. PMID: 22027651

8

The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung.

Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H. Hirvonen A, et al. Among authors: vainio h. Carcinogenesis. 1993 Jul;14(7):1479-81. doi: 10.1093/carcin/14.7.1479. Carcinogenesis. 1993. PMID: 8330369

9

CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour.

Saarikoski ST, Sata F, Husgafvel-Pursiainen K, Rautalahti M, Haukka J, Impivaara O, Järvisalo J, Vainio H, Hirvonen A. Saarikoski ST, et al. Among authors: vainio h. Pharmacogenetics. 2000 Feb;10(1):5-10. doi: 10.1097/00008571-200002000-00002. Pharmacogenetics. 2000. PMID: 10739167 Clinical Trial.

10

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: vainio h. Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11142420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters